{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/ideaya-biosciences-to-initiate-new-drug-application-submission-from-the-darovasertib-optimum-02-trial-under-the-oncology-center-of-excellence-real-time-oncology-review-rtor-program-302758376.html", "message": "News view counter 692444 successfully enlarged"}